Riskpilot← Back to searchSign inGet full accessFerrosan Medical Devices Group A/S
A/SDissolvedCVR 37808342Sydmarken 5Ikke-finansielle holdingselskaber · NACE 642020Est. 2016— employees
Revenue 2022
DKK 810,3M
+12% vs 2021
EBITDA margin
28.6%
-13% vs 2021
Equity ratio
30.8%
Financial strength
Net profit 2022
DKK 136,9M
+33% vs 2021
| Revenue | DKK 810,3M | +12% |
| EBITDA | DKK 231,4M | -13% |
| Net profit | DKK 136,9M | +33% |
| Total assets | DKK 2B | +2% |
| Equity | DKK 620,2M | +10% |
| Employees | — | — |
Legal name
Ferrosan Medical Devices Group A/S
CVR number
37808342
Legal form
Aktieselskab
NACE code
642020 · Ikke-finansielle holdingselskaber
Founded
20. juni 2016
Share capital
DKK 5.156.814
Employees
—
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede bestyrelse eller af to bestyrelsesmedlemmer i forening eller af en direktør i forening med bestyrelsens formand.
Address
Sydmarken 5
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Revenue | -347 | -1.070 | -1.193 | -1.470 | -1.484 | 720.355 | 810.291 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -172.721 | -197.637 |
| EBITDA | -347 | -1.070 | -1.193 | -1.470 | -1.484 | 265.770 | 231.359 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -79.252 | -17.901 |
| EBIT | -347 | -1.070 | -1.193 | -1.470 | -1.484 | 186.518 | 213.458 |
| Net financials | 930 | 1.908 | 199.635 | 276.732 | 997 | -51.044 | -49.128 |
| Profit before tax | 583 | 838 | 198.442 | 275.262 | -487 | 135.474 | 164.330 |
| Tax | 146 | 185 | -175 | -325 | -326 | 32.618 | 27.476 |
| Net profit | 437 | 653 | 198.617 | 275.587 | -161 | 102.856 | 136.854 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Total assets | 841.425 | 844.320 | 810.439 | 810.862 | 811.404 | 1.973.510 | 2.016.023 |
| Equity | 838.287 | 843.940 | 809.939 | 810.795 | 810.759 | 561.709 | 620.234 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 1.081.244 | 1.196.459 |
| Short-term debt | 3.138 | 380 | 500 | 67 | 645 | 330.577 | 199.330 |
| Total debt | 3.138 | 380 | 500 | 67 | 645 | 1.411.801 | 1.395.789 |
EBITDA margin
28.6%
This company
15.8%
Market median
+81% vs market
20162022
Equity ratio
30.8%
This company
38.2%
Market median
+19% vs market
20162022
Return on equity
22.1%
This company
18.4%
Market median
+20% vs market
20162022
Net profit margin
16.9%
This company
8.1%
Market median
+109% vs market
20162022
Asset turnover
0.40×
This company
1.12×
Market median
-64% vs market
20162022
Debt / equity
2.25×
This company
0.62×
Market median
-263% vs market
20162022
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-06-20 – 2016-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
HH Management | Management | 2023 | — | — |
TK Management | Management | 2018 | — | — |
JF Management | Management | 2016 | — | — |
JC Management | Management | 2016 | — | — |
HF Management | Management | 2016 | — | — |
RH Management | Management | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2016 | — | — | |
| Chairman | 2016 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2018 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2017 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2016 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
KIRK KAPITAL A/S | Company | 25.0% | 25.0% | 2016 |
| Individual | 5.0% | 0.0% | 2016 | |
A/S FRYCO | Company | 5.0% | 0.0% | 2016 |
CAPITAL INVEST HOLDING ApS | Company | 10.0% | 0.0% | 2017 |
Ferrosan Medical Devices Group A/S | Company | 90.0% | 90.0% | 2022 |
| Individual | 10.0% | 15.0% | 2016 | |
| Individual | 10.0% | 10.0% | 2020 | |
Toldkammeret 9 ApS | Company | 10.0% | 0.0% | 2016 |
| Individual | 15.0% | 15.0% | 2016 | |
| Individual | 33.3% | 33.3% | 2022 | |
Kirk Kapital Strategic Investments A/S | Company | 25.0% | 25.0% | 2021 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Ferrosan Medical Devices Group A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hans Henrik Pauk Pedersen | Management | 0 companies |
| Thomas Kastrup Sørensen | Management | 0 companies |
| Johan Fredrik Strömholm | Management | 0 companies |
| Johannes Charles Wilhelmus Meulenkamp | Management | 0 companies |
| Henrik Frank Solander Krøis | Management | 0 companies |
| Rasmus Hother le Fevre | Management | 0 companies |
| Marianne Vinding Ovesen | Board of Directors | 0 companies |
| Bjarne Ammitzbøll | Board of Directors | 0 companies |
| Peter Henrik Kürstein-Jensen | Chairman | 0 companies |
| Mia Bielecki | Board of Directors | 0 companies |
| Staffan Percy Ternström | Board of Directors | 0 companies |
| Kim Gulstad | Board of Directors | 0 companies |
| Måns Eskil Barsne | Board of Directors | 0 companies |
| Allan Bjørn Rasmussen | Board of Directors | 0 companies |
| Sven Gustav Sören Mellstig | Chairman | 0 companies |
| Anja Bach Eriksson | Board of Directors | 0 companies |
| Arne Due-Hansen | Board of Directors | 0 companies |
| Nicholas Povl Zilstorff Hooge | Board of Directors | 0 companies |